Wednesday, August 04, 2021 2:03:36 PM
I believe many of those shareholders that bought MONI back at or near its lows are gone. Research the volume history and look at how consistently there seems to have always been a transition of old investors to new investors by researching the volume history of this stock. If things were as you have stated, then the price would have been closer towards its 52 week lows versus its 52 week highs.
They have retired/cancelled 2.1 billion shares and is in the process of retiring/cancelling another 220 million shares. This means that after this next round of eliminating shares, the Outstanding Shares (OS) is going to be... 623,262,060 shares.... I repeat... 623,262,060 shares.
Let's put this in proper perspective for people to truly understand how great the situation is here. I am still holding TSNP (now HMBL) as it went from .0001 to $1.93 per share while having an OS of nearly 4.5 billion shares that later dropped down to nearly 3.9 billion shares. Question??? Do you think people didn't buy TSNP because they didn't get in at or near the bottom? Some people were over there crying that it was frontloaded in the .000s and to stay away from it because of such. Those that took that advice likely missed out on some huge gains.
I am still holding NSAV as it went from .0001 to .1493 per share and expected to go much much higher while having an OS of nearly 6 billion shares. Heck, the same logic above applies. I can post many penny stocks that have had huge moves while having a far greater OS than what we have here with MONI. I'm not because I think those that might of had such a concern truly see my point.
Wait... there's more to consider...
v/r
Sterling
Exit Strategy & Etiquette Thoughts for a Stock
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=128822531
I never give investing advice; only my beliefs for risks in a stock.
Recent MONI News
- ILUS International Inc (ILUS) Sees 557% Q1 Revenue Increase, Begins National Exchange Uplist Procedure for Subsidiaries and Company • InvestorsHub NewsWire • 06/05/2023 12:15:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM